01545nas a2200289   4500000000100000008004100001260001300042653001000055653001100065653001600076653003300092653001100125653001200136653000900148653001600157100001500173700001300188700001400201700001500215700001100230245008100241300001000322490000700332050003200339520087000371022001401241       1983                            d  c1983 Apr10aAdult10aFemale10aHepatitis B10aHepatitis B Surface Antigens10aHumans10aleprosy10aMale10aMiddle Aged1 aKatoch V M1 aKatoch K1 aDutta A K1 aSharma V D1 aRamu G00aHepatitis-B virus infection in patients with leprosy--a brief communication.  a193-60 v55  aInfolep Library - available3 a<p>The prevalence rate of hepatitis-B surface antigen (HBsAg) were determined in 413 patients of different types of leprosy and 133 healthy controls from the same population, in a study undertaken over a period of more than 3 years. The average frequency of australia antigen (HBsAg) was 7.7% in leprosy cases as compared to 6.0% in their healthy counterparts. Across the spectrum 7.2% of lepromatous patients (LL); 8.5% of borderline lepromatous (BL); 9.1% of borderline borderline (BB); 8.6% of borderline tuberculoid (BT) and 8.8% of tuberculoid (TT) cases were positive for HBsAg. Though the prevalence of australia antigen was slightly higher in borderline tuberculoid, borderline borderline and tuberculoid cases, it is not statistically significant. No association between carriership of HBsAg and lepromatous leprosy could be found in the present study.</p>  a0024-1024